BULLISHWHALES
BullishWhales · Congress · Trade Detail
--ENDOCYTE, (INC.)
RepublicanHouse

Curt Clawson sold ENDOCYTE, (INC.) (--)

Curt Clawson (R-FL), a U.S. Representative, has disclosed 188 trades in ENDOCYTE, (INC.) (--) since 2014, 100 purchases and 88 sales, worth an estimated $11M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Curt Clawson sold $15,001 - $50,000 of ENDOCYTE, (INC.) (--) on September 29, 2016. Since that trade, -- is up +0.00% against the S&P 500 up +307.73%, an outperformance of -307.73%.

Across these filings, Curt Clawson has been a net buyer of -- (a buy-to-sell ratio of 1.14). The most recent disclosed -- transaction shown was dated December 27, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

-- trades
188
Disclosed Vol
$11M
Buys
100
53%
Sells
88
47%
Buy / Sell
1.14
ratio
First → Last
2014–2016

Curt Clawson's -- trades vs the price

-- is up +0.00% since Curt Clawson sold on September 29, 2016, versus +307.73% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+307.73%
Outperformance vs S&P 500
-307.73%

All Curt Clawson -- trades

TradedTypeSizeReturnEst. profit
December 27, 2016SELL$15,001 - $50,000N/A
December 14, 2016BUY$1,001 - $15,000N/A
December 2, 2016BUY$1,001 - $15,000N/A
November 15, 2016BUY$1,001 - $15,000N/A
October 3, 2016BUY$1,000,001 - $5,000,000N/A
September 29, 2016SELL$15,001 - $50,000N/A
September 15, 2016BUY$1,001 - $15,000N/A
August 24, 2016BUY$1,001 - $15,000N/A
August 12, 2016SELL$15,001 - $50,000N/A
July 28, 2016SELL$1,000,001 - $5,000,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Curt Clawson & -- trading FAQ

Is it legal for Curt Clawson to trade ENDOCYTE, (INC.) (--) stock?

Yes. Members of Congress are allowed to trade individual stocks, including ENDOCYTE, (INC.) (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did Curt Clawson sell --?

Curt Clawson disclosed a sale of $15,001 - $50,000 of ENDOCYTE, (INC.) (--) on September 29, 2016, according to public STOCK Act filings.

How has -- performed since Curt Clawson's trade?

Since Curt Clawson sold -- on September 29, 2016, the stock is up +0.00%, versus +307.73% for the S&P 500 over the same period, an outperformance of -307.73%.

How many times has Curt Clawson traded --?

Curt Clawson has disclosed 188 -- trades since 2014 (100 purchases and 88 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional -- trades?

BullishWhales tracks every disclosed congressional trade in ENDOCYTE, (INC.) (--) on the ENDOCYTE, (INC.) congressional trading page, which aggregates filings across all members of Congress.

Curt Clawson's -- tradesAll congressional filings for ENDOCYTE, (INC.)Curt Clawson's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30